References
- WHO. World Health Organization. Hepatitis A fact sheet; 2017. http://www.who.int/mediacentre/factsheets/fs328/en/.
- Feng Z, Hirai-Yuki A, McKnight KL, et al. Naked viruses that aren’t always naked: quasi-enveloped agents of acute hepatitis. Annu Rev Virol. 2014;1:539–16.
- Scholz E, Heinricy U, Flehmig B. Acid stability of hepatitis A virus. J Gen Virol. 1989;70(9):2481–2485.
- Siegl G, Weitz M, Kronauer G. Stability of hepatitis A virus. Intervirology. 1984;22:218–226.
- Graff J, Richards OC, Swiderek KM, et al. Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol. 1999;73:6015–6023.
- Yang X, Cheng A, Wang M, et al. Structures and corresponding functions of five types of Picornaviral 2A proteins. Front Microbiol. 2017;8:1373.
- Harmon SA, Emerson SU, Huang YK, et al. Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol. 1995;69:5576–5581.
- Cohen L, Benichou D, Martin A. Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis. J Virol. 2002;76:7495–7505.
- Anderson DA, Ross BC. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol. 1990;64:5284–5289.
- Feng Z, Hensley L, McKnight KL, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013;496:367–371.
- Wang X, Ren J, Gao Q, et al. Hepatitis A virus and the origins of picornaviruses. Nature. 2015;517:85–88.
- Demirov DG, Freed EO. Retrovirus budding. Virus Res. 2004;106:87–102.
- Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011;21:77–91.
- Strack B, Calistri A, Craig S, et al. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell. 2003;114:689–699.
- Bird SW, Maynard ND, Covert MW, et al. Nonlytic viral spread enhanced by autophagy components. Proc Natl Acad Sci USA. 2014;111:13081–13086.
- Chen YH, Du W, Hagemeijer MC, et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160:619–630.
- Takahashi M, Yamada K, Hoshino Y, et al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol. 2008;153:1703–1713.
- Emerson SU, Nguyen HT, Torian U, et al. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol. 2010;84:9059–9069.
- Yin X, Ambardekar C, Lu Y, et al. Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses. J Virol. 2016;90:4232–4242.
- McKnight KL, Xie L, Gonzalez-Lopez O, et al. Protein composition of the hepatitis A virus quasi-envelope. Proc Natl Acad Sci USA. 2017;114:6587–6592.
- Tkach M, Kowal J, Thery C. Why the need and how to approach the functional diversity of extracellular vesicles. Philos Trans R Soc Lond B Biol Sci. 2018;373: 20160479.
- Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364–372.
- McKnight KL, Xie L, González-López O, et al. Protein composition of the hepatitis A virus quasi-envelope. Proc Nat Acad Sci. 2017;7: 201619519–13.
- Robinson SM, Tsueng G, Sin J, et al. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog. 2014;10:e1004045.
- Votteler J, Sundquist WI. Virus budding and the ESCRT pathway. Cell Host Microbe. 2013;14:232–241.
- Gonzalez-Lopez O, Rivera-Serrano EE, Hu F, et al. Redundant late domain functions of tandem VP2 YPX3L motifs in nonlytic cellular egress of quasi-enveloped hepatitis A virus. J Virol. 2018;92:e01308-18.
- Fisher RD, Chung HY, Zhai Q, et al. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell. 2007;128:841–852.
- Hirai-Yuki A, Hensley L, Whitmire JK, et al. Biliary secretion of quasi-enveloped human hepatitis A virus. MBio. 2016;7:e01998-16.
- Ruchti F, Siegl G, Weitz M. Identification and characterization of incomplete hepatitis A virus particles. J Gen Virol. 1991;72(9):2159–2166.
- Bishop NE, Anderson DA. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology. 1993;197:616–623.
- Feinstone SM, Kapikian AZ, Gerin JL, et al. Buoyant density of the hepatitis A virus-like particle in cesium chloride. J Virol. 1974;13:1412–1414.
- Deng L, Jiang W, Wang X, et al. Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes. J Hepatol. 2019;71:52–61.
- Vahey MD, Fletcher DA. Low-fidelity assembly of influenza A virus promotes escape from host cells. Cell. 2018. DOI:10.1016/j.cell.2018.10.056
- Yim N, Choi C. Extracellular vesicles as novel carriers for therapeutic molecules. BMB Rep. 2016;49:585–586.
- Yim N, Ryu SW, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016;7:12277.
- Jiang W, Muhammad F, Ma P, et al. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antiviral Res. 2018;154:51–57.
- Yang Z, Wang X, Chi X, et al. Neglected but important role of apolipoprotein E exchange in hepatitis C virus infection. J Virol. 2016;90:9632–9643.
- Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012;e3037. DOI:10.3791/3037